ArticleCase reports in oncological medicine2026
Testicular Embryonal Carcinoma With Retroperitoneal Metastasis and Normal AFP and HCG: A Case Report.
Article in Case reports in oncological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Testicular Embryonal Carcinoma With Retroperitoneal Metastasis and Normal AFP and HCG: A Case Report.Case reports in oncological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Testicular germ cell tumors are common malignant tumors in young men, among which embryonal carcinoma, as an important subtype of non-seminomatous germ cell tumors, is usually accompanied by elevated serum tumor markers. This case report describes a 24-year-old male patient with testicular embryonal carcinoma and retroperitoneal lymph node metastasis, yet with persistently normal serum markers, posing significant diagnostic challenges. Diagnosis was ultimately confirmed through imaging, histopathology, and immunohistochemical analysis. The patient underwent radical orchiectomy followed by standard bleomycin, etoposide, and cisplatin (BEP) chemotherapy and showed no recurrence at 12-month follow-up. This case highlights the necessity of a multidisciplinary diagnostic approach, integrating clinical evaluation, imaging, and immunohistochemistry, to ensure accurate diagnosis, particularly in marker-negative presentations. It also confirms the efficacy of established treatment protocols and emphasizes the importance of heightened clinical vigilance and long-term follow-up for such atypical cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.